<!DOCTYPE html PUBLIC "-//W3C//DTD XHTML 1.0 Transitional//EN" "http://www.w3.org/TR/xhtml1/DTD/xhtml1-transitional.dtd">
<html xmlns="http://www.w3.org/1999/xhtml">
<head>
  <meta http-equiv="Content-Type" content="text/html; charset=utf-8" />
  <meta http-equiv="Content-Style-Type" content="text/css" />
  <meta name="generator" content="pandoc" />
  <title></title>
  <style type="text/css">code{white-space: pre;}</style>
</head>
<body>
<h3 id="mondo0017595"><a href="http://purl.obolibrary.org/obo/MONDO_0017595">MONDO:0017595</a></h3>
<p><strong>Label:</strong> aggressive b-cell non-Hodgkin lymphoma</p>
<p><strong>Subclasses:</strong> <a href="http://purl.obolibrary.org/obo/MONDO_0015818">MONDO:0015818</a> (aggressive primary cutaneous b-cell lymphoma), <a href="http://purl.obolibrary.org/obo/MONDO_0007243">MONDO:0007243</a> (Burkitts lymphoma), <a href="http://purl.obolibrary.org/obo/MONDO_0018905">MONDO:0018905</a> (diffuse large b-cell lymphoma), <a href="http://purl.obolibrary.org/obo/MONDO_0020511">MONDO:0020511</a> (precursor b-cell acute lymphoblastic leukemia),</p>
<p><strong>Corr. equiv. classes:</strong> <a href="http://www.orpha.net/ORDO/Orphanet_99860">Orphanet:99860</a>, <a href="http://purl.obolibrary.org/obo/OMIM_615545">OMIM:615545</a>, <a href="http://www.orpha.net/ORDO/Orphanet_178554">Orphanet:178554</a>, <a href="http://www.orpha.net/ORDO/Orphanet_544">Orphanet:544</a>, <a href="http://www.orpha.net/ORDO/Orphanet_543">Orphanet:543</a>, <a href="http://purl.obolibrary.org/obo/OMIM_113970">OMIM:113970</a>,</p>
<p><strong>Class expressions from DL-Learner:</strong></p>
<ul>
<li><a href="http://purl.obolibrary.org/obo/HP_0001871">HP:0001871</a> (Abnormality of blood and blood-forming tissues) and <a href="http://purl.obolibrary.org/obo/HP_0011793">HP:0011793</a> (Neoplasm by anatomical site) 22.87%</li>
<li><a href="http://purl.obolibrary.org/obo/HP_0001871">HP:0001871</a> (Abnormality of blood and blood-forming tissues) and <a href="http://purl.obolibrary.org/obo/HP_0002664">HP:0002664</a> (Neoplasm) 22.60%</li>
<li><a href="http://purl.obolibrary.org/obo/HP_0011793">HP:0011793</a> (Neoplasm by anatomical site) 20.19%</li>
<li><a href="http://purl.obolibrary.org/obo/HP_0002664">HP:0002664</a> (Neoplasm) and (not (<a href="http://purl.obolibrary.org/obo/HP_0000003">HP:0000003</a> (Multicystic kidney dysplasia))) 20.05%</li>
<li><a href="http://purl.obolibrary.org/obo/HP_0002664">HP:0002664</a> (Neoplasm) and (not (<a href="http://purl.obolibrary.org/obo/HP_0000011">HP:0000011</a> (Neurogenic bladder))) 20.04%</li>
<li><a href="http://purl.obolibrary.org/obo/HP_0002664">HP:0002664</a> (Neoplasm) and (not (<a href="http://purl.obolibrary.org/obo/HP_0000016">HP:0000016</a> (Urinary retention))) 20.03%</li>
<li><a href="http://purl.obolibrary.org/obo/HP_0002664">HP:0002664</a> (Neoplasm) and (not (<a href="http://purl.obolibrary.org/obo/HP_0000013">HP:0000013</a> (Hypoplasia of the uterus))) 20.03%</li>
<li><a href="http://purl.obolibrary.org/obo/HP_0002664">HP:0002664</a> (Neoplasm) 20.03%</li>
<li><a href="http://purl.obolibrary.org/obo/HP_0002664">HP:0002664</a> (Neoplasm) and (not (<a href="http://purl.obolibrary.org/obo/HP_0000017">HP:0000017</a> (Nocturia))) 20.03%</li>
<li><a href="http://purl.obolibrary.org/obo/HP_0002664">HP:0002664</a> (Neoplasm) and (not (<a href="http://purl.obolibrary.org/obo/HP_0000012">HP:0000012</a> (Urinary urgency))) 20.03%</li>
<li><a href="http://purl.obolibrary.org/obo/HP_0002664">HP:0002664</a> (Neoplasm) and (not (<a href="http://purl.obolibrary.org/obo/HP_0000004">HP:0000004</a> (null))) 20.03%</li>
<li><a href="http://purl.obolibrary.org/obo/HP_0001871">HP:0001871</a> (Abnormality of blood and blood-forming tissues) 19.58%</li>
<li><a href="http://purl.obolibrary.org/obo/HP_0000118">HP:0000118</a> (Phenotypic abnormality) 17.83%</li>
<li>Thing 17.83%</li>
<li><a href="http://purl.obolibrary.org/obo/HP_0000001">HP:0000001</a> (All) 17.83%</li>
</ul>
</body>
</html>
